Results 161 to 170 of about 6,107 (224)

High-Stakes Hormone: Vasopressin Use as a Last-Line Therapy for Shock in Pediatrics-A Narrative Review. [PDF]

open access: yesReports (MDPI)
Sota M   +4 more
europepmc   +1 more source

Point-of-care Ultrasonography in Patients with Hepatorenal Syndrome: A Single Center Observational Study. [PDF]

open access: yesIndian J Crit Care Med
Amara V   +12 more
europepmc   +1 more source

Defining Renal Recovery in Patients With Hepatorenal Syndrome-Acute Kidney Injury: Experience From North American Studies. [PDF]

open access: yesJGH Open
Mujtaba MA   +10 more
europepmc   +1 more source

Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography

Hepatology, 2023
Background and Aims: Treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI), with terlipressin and albumin, provides survival benefits, but may be associated with cardiopulmonary complications. We analyzed the predictors of terlipressin response
M. Premkumar   +19 more
semanticscholar   +1 more source

Impact of long-term continuous terlipressin infusion on the renin-angiotensin-aldosterone system in patients with decompensated cirrhosis

Frontline Gastroenterology
Background and aims Pooling of blood in the splanchnic circulation due to cirrhotic portal hypertension reduces effective circulating blood volume and activates the renin-angiotensin-aldosterone system (RAAS).
R. Terbah   +7 more
semanticscholar   +1 more source

Continuous home terlipressin infusion increases handgrip strength and reduces ascites—A prospective randomized crossover study

Hepatology
Background and Aims: Observational studies suggest a beneficial effect of continuous terlipressin infusion (CTI) on ascites and sarcopenia in decompensated cirrhosis with portal hypertension.
R. Terbah   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy